Skip to content

An Observational Study Using Multimodal Sensors to Measure Cognitive Health in Adults and Distinguish Mild Cognitive Impairment From Normal Aging

An Observational Study Using Multimodal Sensors to Measure Cognitive Health in Adults and Distinguish Mild Cognitive Impairment From Normal Aging

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05058950
Acronym
Intuition
Enrollment
22720
Registered
2021-09-28
Start date
2021-09-20
Completion date
2023-09-19
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment, Normal Aging

Brief summary

The primary objectives are to develop and validate a classifier using multimodal passive sensor data and metrics derived from normal iPhone and Apple Watch usage to distinguish individuals with normal cognition from those with mild cognitive impairment (MCI) and to develop and validate a cognitive wellness score that tracks fluctuations in cognitive performance over time using multimodal passive sensor data and metrics derived from normal iPhone and Apple Watch usage.

Interventions

None listed

Sponsors

Apple Inc.
CollaboratorINDUSTRY
Biogen
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 86 Years
Healthy volunteers
Yes

Inclusion criteria

Key Inclusion Criteria: * Fluent in spoken and written English * Minimum 8 years of education or 8th grade equivalent. * Willing to authorize the use of confidential health information in accordance with applicable privacy regulations. * Willing to wear an Apple Watch for daily use for the duration of the study. * Willing to use their personal iPhone for routine daily use for the duration of the study. * Technical requirements: iPhone models: iPhone 8 or newer iOS versions: current publicly available iOS version * Access to one of the following personal computing devices. Microsoft Windows based personal computers (laptops and desktops) Mac personal computers (laptops and desktops) Apple iPad tablets * Access to WiFi or hardwired internet access in participant's place of residence. * Active email address for enrollment account creation and for use in relaying study information. * Active mobile telephone number for use in relaying study information when appropriate. * Primary address within the United States (50 states and Washington, DC; not a post office (PO) box). Key

Exclusion criteria

* Inability to comply with study requirements. * Any self-reported medical history of dementia (such as Alzheimer's disease, frontotemporal dementia, dementia with Lewy body, vascular dementia, rapidly progressive dementia, or Parkinson's disease dementia). * Self-reported dependence on others to perform core activities of daily living, including feeding, dressing, bathing, toileting, or grooming. NOTE: Other protocol defined Inclusion/

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and Specificity of the Classifier in Distinguishing Between Individuals With and Without MCIUp to Month 23A classifier is a mathematical function that uses collected data to calculate the probability that an individual belongs in a given category. The reference standard for the classifier is clinical diagnosis of MCI in normal clinical care or in a research cohort.
Correlation Between the Cognitive Wellness Score and the Neuropsychological Testing Battery ScoreUp to Month 23To develop and validate a cognitive wellness score that tracks fluctuations in cognitive performance over time using multimodal passive sensor data and metrics derived from normal iPhone and Apple Watch usage.

Secondary

MeasureTime frameDescription
Sensitivity and Specificity of the Classifier in Predicting Between Individuals Who Do and Do Not Develop MCIUp to Month 23A classifier is a mathematical function that uses collected data to calculate the probability that an individual belongs in a given category. The reference standard for the classifier is clinical diagnosis of MCI in normal clinical care or in a research cohort.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026